TTS PHARMA company contrib to 13873- KTP: Prospecting hemp extract as an innovative anti-inflammatory therapy for porcine and equine mating-induced endometritis

Project: Externally funded research

Project Details

StatusFinished
Effective start/end date01 Aug 202131 Jul 2023

Funding

  • TTS Pharma Ltd (98015): £104,172.17